1. Home
  2. PODD vs KEY Comparison

PODD vs KEY Comparison

Compare PODD & KEY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PODD
  • KEY
  • Stock Information
  • Founded
  • PODD 2000
  • KEY 1825
  • Country
  • PODD United States
  • KEY United States
  • Employees
  • PODD N/A
  • KEY N/A
  • Industry
  • PODD Medical/Dental Instruments
  • KEY Major Banks
  • Sector
  • PODD Health Care
  • KEY Finance
  • Exchange
  • PODD Nasdaq
  • KEY Nasdaq
  • Market Cap
  • PODD 16.5B
  • KEY 19.4B
  • IPO Year
  • PODD 2007
  • KEY N/A
  • Fundamental
  • Price
  • PODD $282.80
  • KEY $16.94
  • Analyst Decision
  • PODD Buy
  • KEY Buy
  • Analyst Count
  • PODD 16
  • KEY 20
  • Target Price
  • PODD $291.81
  • KEY $19.40
  • AVG Volume (30 Days)
  • PODD 598.2K
  • KEY 11.6M
  • Earning Date
  • PODD 02-20-2025
  • KEY 04-17-2025
  • Dividend Yield
  • PODD N/A
  • KEY 4.84%
  • EPS Growth
  • PODD 96.40
  • KEY N/A
  • EPS
  • PODD 5.78
  • KEY N/A
  • Revenue
  • PODD $2,071,600,000.00
  • KEY $4,239,000,000.00
  • Revenue This Year
  • PODD $23.56
  • KEY N/A
  • Revenue Next Year
  • PODD $18.07
  • KEY $7.18
  • P/E Ratio
  • PODD $48.93
  • KEY N/A
  • Revenue Growth
  • PODD 22.07
  • KEY N/A
  • 52 Week Low
  • PODD $160.19
  • KEY $13.11
  • 52 Week High
  • PODD $289.46
  • KEY $20.04
  • Technical
  • Relative Strength Index (RSI)
  • PODD 54.94
  • KEY 38.92
  • Support Level
  • PODD $270.00
  • KEY $17.18
  • Resistance Level
  • PODD $288.95
  • KEY $18.08
  • Average True Range (ATR)
  • PODD 6.83
  • KEY 0.43
  • MACD
  • PODD -0.31
  • KEY -0.05
  • Stochastic Oscillator
  • PODD 65.78
  • KEY 0.85

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 425,000 insulin-dependent diabetics are using it worldwide.

About KEY KeyCorp

With assets of over $180 billion, Ohio-based KeyCorp's bank footprint spans 16 states, but it is predominantly concentrated in its two largest markets: Ohio and New York. KeyCorp is primarily focused on serving middle-market commercial clients through a hybrid community/corporate bank model.

Share on Social Networks: